Predict your next investment

Investment Bank
FINANCE | Investment Banking
svbleerink.com

See what CB Insights has to offer

Investments

28

Portfolio Exits

17

Funds

5

Service Providers

1

About SVB Leerink

SVB Leerink is a specialist investment bank focusing on the healthcare sector, headquartered in Boston, Massachusetts.

SVB Leerink Headquarter Location

1 Federal Street 37th Floor

Boston, Massachusetts, 02110,

United States

617-918-4000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest SVB Leerink News

AbbVie (ABBV) Stock: $140 Price Target From SVB Leerink

May 24, 2022

The shares of AbbVie Inc (NYSE: ABBV) have received a $140 price target from SVB Leerink. These are the details. The shares of AbbVie Inc (NYSE: ABBV) have received a $140 price target from SVB Leerink. And SVB Leerink analyst David Risinger initiated coverage of AbbVie with an “Underperform” rating. Risinger noted that management has delivered exceptional performance, but he is projecting 2024-2025 EPS 6%-8% below consensus due to Humira biosimilar pressures accelerating in mid-2023 when several biosimilars launch and AbbVie’s business reinvestment requirements. Currently, Risinger sees the stock as a crowded defensive play and anticipates downward analyst revisions ahead for 2024-2025 EPS as AbbVie’s financial picture becomes clearer. Plus Risinger respects the management team’s execution and performance to date. Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.

SVB Leerink Investments

28 Investments

SVB Leerink has made 28 investments. Their latest investment was in Umoja Biopharma as part of their Series B on June 6, 2021.

CBI Logo

SVB Leerink Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/15/2021

Series B

Umoja Biopharma

$210M

Yes

13

12/14/2020

Series B

LocanaBio

$100M

Yes

28

8/4/2020

Series C

Kinnate Biopharma

$98M

Yes

5

4/6/2020

Series E

Subscribe to see more

$99M

Subscribe to see more

10

1/10/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/15/2021

12/14/2020

8/4/2020

4/6/2020

1/10/2020

Round

Series B

Series B

Series C

Series E

Series C

Company

Umoja Biopharma

LocanaBio

Kinnate Biopharma

Subscribe to see more

Subscribe to see more

Amount

$210M

$100M

$98M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

13

28

5

10

10

SVB Leerink Portfolio Exits

17 Portfolio Exits

SVB Leerink has 17 portfolio exits. Their latest portfolio exit was Vera Whole Health on July 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/1/2021

Acq - Fin

$99M

2

3/22/2021

Acquired

$99M

8

12/3/2020

IPO

$99M

11

7/30/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/12/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2021

3/22/2021

12/3/2020

7/30/2020

6/12/2020

Exit

Acq - Fin

Acquired

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

8

11

10

10

SVB Leerink Fund History

5 Fund Histories

SVB Leerink has 5 funds, including Leerink Revelation Partners Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/12/2018

Leerink Revelation Partners Fund II

$227M

1

9/29/2017

Health IT Growth Equity Fund I

$99M

10

7/6/2016

Leerink Transformation Fund I

$99M

10

6/11/2015

LEERINK Revelation Partners

$99M

10

Massachusetts Innovation Catalyst Fund

10

Closing Date

6/12/2018

9/29/2017

7/6/2016

6/11/2015

Fund

Leerink Revelation Partners Fund II

Health IT Growth Equity Fund I

Leerink Transformation Fund I

LEERINK Revelation Partners

Massachusetts Innovation Catalyst Fund

Fund Type

Status

Amount

$227M

$99M

$99M

$99M

Sources

1

10

10

10

10

SVB Leerink Service Providers

1 Service Provider

SVB Leerink has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

SVB Leerink Team

20 Team Members

SVB Leerink has 20 team members, including current Chief Executive Officer, Jeffrey A. Leerink.

Name

Work History

Title

Status

Jeffrey A. Leerink

Chief Executive Officer

Current

Joseph Gentile

Chief Administrative Officer

Current

James Boylan

Senior Managing Director

Current

Doug Brown

Senior Managing Director

Current

Jon Civitarese

Managing Director

Current

Name

Jeffrey A. Leerink

Joseph Gentile

James Boylan

Doug Brown

Jon Civitarese

Work History

Title

Chief Executive Officer

Chief Administrative Officer

Senior Managing Director

Senior Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.